CLASSIFICATION OF POSITIVE INOTROPIC AGENTS

被引:32
作者
FELDMAN, AM
机构
[1] Peter Belfer Cardiac Laboratories, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD
关键词
D O I
10.1016/0735-1097(93)90441-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although there is increasing recognition that all inotropic agents are not alike, they continue to be viewed in the generic sense because of the lack of a classification system. Analogous to the classification system proposed for the antiarrhythmic agents over 20 years ago, a classification system is proposed that categorizes inotropic agents according to their mechanisms of action. Agents are classified as those that augment contractility by increasing intracellular levels of cyclic adenosine monophosphate (class I); affect ion channels or pumps (class II); modulate intracellular calcium regulation (class III), and augment contractility through multiple pathways (class IV). This classification system does not suggest that some classes of inotropic agents might be more effective than others nor does it imply that potential beneficial effects are shared by all members of each class of drugs. However, it provides a framework for better understanding of the potential benefits and limitations of the traditional inotropic agents as well as the increasing number of new investigational drugs.
引用
收藏
页码:1223 / 1227
页数:5
相关论文
共 52 条
[1]  
[Anonymous], 1990, Lancet, V336, P1
[2]   OUTPATIENT DOBUTAMINE AND DOPAMINE INFUSIONS IN THE MANAGEMENT OF CHRONIC HEART-FAILURE - CLINICAL-EXPERIENCE IN 21 PATIENTS [J].
APPLEFELD, MM ;
NEWMAN, KA ;
SUTTON, FJ ;
REED, WP ;
ROFFMAN, DS ;
TALESNICK, BS ;
GROVE, WR .
AMERICAN HEART JOURNAL, 1987, 114 (03) :589-595
[3]   HEMODYNAMIC ASSESSMENT OF AMRINONE - NEW INOTROPIC AGENT [J].
BENOTTI, JR ;
GROSSMAN, W ;
BRAUNWALD, E ;
DAVOLOS, DD ;
ALOUSI, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (25) :1373-1377
[4]   CONTRIBUTION OF CAMP-PHOSPHODIESTERASE INHIBITION AND SENSITIZATION OF THE CONTRACTILE PROTEINS FOR CALCIUM TO THE INOTROPIC EFFECT OF PIMOBENDAN IN THE FAILING HUMAN MYOCARDIUM [J].
BOHM, M ;
MORANO, I ;
PIESKE, B ;
RUEGG, JC ;
WANKERL, M ;
ZIMMERMANN, R ;
ERDMANN, E .
CIRCULATION RESEARCH, 1991, 68 (03) :689-701
[5]  
BRISTOW MR, 1990, CIRCULATION, V82, P12
[6]   POSITIVE INOTROPIC AND LUSITROPIC EFFECTS OF INTRAVENOUS FLOSEQUINAN IN PATIENTS WITH HEART-FAILURE [J].
BURSTEIN, S ;
SEMIGRAN, MJ ;
DEC, GW ;
BOUCHER, CA ;
FIFER, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (04) :822-829
[7]   DO POSITIVE INOTROPIC AGENTS ADVERSELY AFFECT THE SURVIVAL OF PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE .1. INTRODUCTION [J].
CODY, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (02) :559-561
[8]   THE PREVENTION OF HEART-FAILURE - A NEW AGENDA [J].
COHN, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) :725-727
[9]   DECREASED LYMPHOCYTE BETA-ADRENERGIC-RECEPTOR DENSITY IN PATIENTS WITH HEART-FAILURE AND TOLERANCE TO THE BETA-ADRENERGIC AGONIST PIRBUTEROL [J].
COLUCCI, WS ;
ALEXANDER, RW ;
WILLIAMS, GH ;
RUDE, RE ;
HOLMAN, BL ;
KONSTAM, MA ;
WYNNE, J ;
MUDGE, GH ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (04) :185-190
[10]   INTRACORONARY INFUSION OF DOBUTAMINE TO PATIENTS WITH AND WITHOUT SEVERE CONGESTIVE HEART-FAILURE - DOSE-RESPONSE RELATIONSHIPS, CORRELATION WITH CIRCULATING CATECHOLAMINES, AND EFFECT OF PHOSPHODIESTERASE INHIBITION [J].
COLUCCI, WS ;
DENNISS, AR ;
LEATHERMAN, GF ;
QUIGG, RJ ;
LUDMER, PL ;
MARSH, JD ;
GAUTHIER, DF .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) :1103-1110